| 23176/34351 | US=46 / Enfermagem Santoro DC, Souza ECO, Stipp MAC, Carvalho SM. O cliente com distúrbios de saúde por alterações eletrocardiográficas. In: Figueiredo NMA, Stipp MAC, Leite JL. Cardiopatias: avaliação e intervenção em enfermagem. São Caetano do Sul: Yendis, 2008. p. 161-225. ISBN 85-7728047-6. IMPULSO CARDIACO; ARRITMIA; ELETROCARDIOGRAFIA; TAQUIARRITMIA; TAQUICARDIA; ECOCARDIOGRAMA; TAQUIARRITMIA SUPRAVENTRICULAR; TAQUICARDIA SINUSAL; TAQUICARDIA SUPRAVENTRICULAR PAROXISTICA; FLUTTER ATRIAL; FIBRILACAO ATRIAL; TAQUICARDIA SUPRAVENTRICULAR PAROXISTICA POR REENTRADA SINOATRIAL; TAQUICARDIA JUNCIONAL NAO-PAROXISTICA; TAQUICARDIA VENTRICULAR; RITMO IDIOVENTRICULAR ACELERADO; FIBRILACAO VENTRICULAR; BRADIARRITMIA; BRADICARDIA SINUSAL; MARCA-PASSO TRANSVENOSO; BLOQUEIO CARDIACO; BLOQUEIO ATRIOVENTRICULAR; BLOQUEIO INTRAVENTRICULAR |
| 23177/34351 | US=46 / Enfermagem Rodrigues ARB. Marca-passo cardíaco provisório. In: Figueiredo NMA, Stipp MAC, Leite JL. Cardiopatias: avaliação e intervenção em enfermagem. São Caetano do Sul: Yendis, 2008. p. 227-52. ISBN 85-7728047-6. MARCA-PASSO CARDIACO PROVISORIO. TIPOS; MARCA-PASSO CARDIACO PROVISORIO. INDICACOES DE USO; GERADOR DE PULSO; ASSISTENCIA DE ENFERMAGEM |
| 23178/34351 | US=46 / Enfermagem Leite JL, Fonseca JM, Braz MR, Nascimento MTF. Pré e pós-operatório de cirurgia cardíaca. In: Figueiredo NMA, Stipp MAC, Leite JL. Cardiopatias: avaliação e intervenção em enfermagem. São Caetano do Sul: Yendis, 2008. p. 253-93. ISBN 85-7728047-6. CORACAO. CIRURGIA; PRE-OPERATORIO; POS-OPERATORIO; DOENCA CARDIOVASCULAR; CIRURGIA CARDIACA; INTERVENCOES DE ENFERMAGEM; COMPLICACOES POS-OPERATORIO |
| 23179/34351 | US=46 / Enfermagem Stipp CA, Leite JL, Stipp MAC, Santos NMP, Machado SC. Enfermagem na reabilitação cardíaca. In: Figueiredo NMA, Stipp MAC, Leite JL. Cardiopatias: avaliação e intervenção em enfermagem. São Caetano do Sul: Yendis, 2008. p. 295-329. ISBN 85-7728047-6. |
| 23180/34351 | US=47 / Câncer Knudsen ES, Braden WA. RB-pathway: cell control and cancer therapy. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 1-17. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. VIA RB; CONTROLE DO CANCER; TERAPIA CELULAR; SUPRESSOR DE TUMOR; RETINOBLASTOMA; CICLINAS; QUIMIOTERAPIA; TERAPIA DE ALVO MOLECULAR; CICLO CELULAR; E2F; ANTIMETABOLITOS; AGENTES ANTIMICROTUBULOS |
| 23181/34351 | US=47 / Câncer Klein C, Vassilev LT. Targeting the p53/MDM2 pathway for cancer therapy. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 19-56. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. SEGMENTACAO DA VIA P53/MDM2; TERAPIA DE CANCER; PROTEINA P53; MDM2; SUPRESSOR DE TUMOR; INTERACAO PROTEINA-PROTEINA; INTERACAO P53-MDM2 |
| 23182/34351 | US=47 / Câncer Bender RP, Osheroff N. DNA topoisomerases as targets for the chemotherapeutic treatment of cancer. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 57-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. TOPOISOMERASES DE DNA; CANCER. TERAPIA; QUIMIOTERAPIA; TOPOISOMERASE II; TOPOISOMERASE IIALFA; TOPOISOMERASE IIBETA; TOPOISOMERASE II POISONS; FARMACOS ANTICANCERIGENOS; GENOTOXICIDADE; LEUCEMIA; DNA SUPERCOILING; LESAO DNA |
| 23183/34351 | US=47 / Câncer Ackermann JM, El-Deiry WS. Targeting ATM/ATR in the DNA damage checkpoint. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 93-116. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. SEGMENTACAO ATM/ATR; DANOS AO DNA; ATAXIA TELANGIECTASIA; RADIACAO IONIZANTE; FOSFORILACAO |
| 23184/34351 | US=47 / Câncer Kawabe T. Compounds that abrogate the G2 checkpoint. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 117-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. CICLO CELULAR; G1; G2; ONCOGENESE; TERAPIA DO CANCER; DANOS AO DNA; REPARO DO DNA; MUTACAO |
| 23185/34351 | US=47 / Câncer Yap TA, Molife LR, Bono JS. CDK inhibitors as anticancer agents. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 135-62. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. INIBIDORES DE CDK; AGENTES ANTICANCERIGENOS; CICLO CELULAR; CICLINA DEPENDENTE DE QUINASE; CICLINA; INIBIDOR; FLAVOPIRIDOL; UCN-01; E7070; SELICICLIB; BMS 387032; ZD 304709 |
| 23186/34351 | US=47 / Câncer Toyota M, Kashima L, Tokino T. CHFR as a potential anticancer target. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 163-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. CHFR; AGENTE ANTICANCERIGENO; CHECKPOINT MITOTICO; CHECKPOINT PROFASE; TUBULINA; UBIQUITINA LIGASE E3; MITOSE |
| 23187/34351 | US=47 / Câncer Villalona-Calero MA, Schaaf L, Turowski R. Antimicrotubule agents. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 177-205. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. AGENTES ANTIMICROTUBULOS; TUBULINA; ALCALOIDES DA VINCA; TAXANOS; EPOTILONAS; RESISTENCIA TUMOR; ALBUMINA |
| 23188/34351 | US=47 / Câncer Sarli V, Giannis A. Kinesin motor inhibitors as effective anticancer drugs. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 207-26. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. INIBIDORES KINESIN; DROGAS ANTICANCER; KINESINAS; ANTIMITOTICOS; EG5 HUMANA |
| 23189/34351 | US=47 / Câncer Kang J, Yu H. Targeting the spindle checkpoint in cancer chemotherapy. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 227-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. SEGMENTACAO DO CHECKPOINT MITOTICO; QUIMIOTERAPIA; MITOSE; SEGREGACAO DOS CROMOSSOMOS; CHECKPOINT MITOTICO; ANEUPLOIDIA; ANAFASE; UBIQUITINACAO; ANTIMITOTICOS; MAD2; CDC20; BUB1 |
| 23190/34351 | US=47 / Câncer Shakalya K, Mahadevan D. Antiproliferation inhibitors targeting aurora kinases. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 243-69. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. INIBIDORES ANTI-PROLIFERACAO; AURORA QUINASE; MITOSE; CICLO CELULAR; PROTO-ONCOGENES; INIBIDORES DA PROTEINA-QUINASE; ANEUPLOIDIA; CITOCINESE |
| 23191/34351 | US=47 / Câncer Dai W, Yang Y, Jiang N. Plks as novel targets for cancer drug design. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 271-90. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. PLKS; MEDICAMENTO ANTICANCER; POLO-LIKE QUINASES; PLK1; MITOSE; INIBIDORES; DROGAS ANTI-CANCER; FOSFORILACAO |
| 23192/34351 | US=47 / Câncer Gabrielli B, Stevens F, Beamish H. Do histone deacetylase inhibitors target cell cycle checkpoints that monitor heterochromatin structure?. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 291-309. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. INIBIDORES DAS HISTONAS DESACETILASES; CONTROLE DO CICLO CELULAR; HETEROCROMATINA; LETALIDADE SINTETICA; PASSAGEIROS CROMOSSOMICOS |
| 23193/34351 | US=44 / Gastro Dellon ES, Shaheen NJ. Epidemiology of gastroesophageal cancer. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 3-13. ISBN 978-1-4051-2783-7. CANCER GASTROESOFAGICO. EPIDEMIOLOGIA; CANCER DE ESOFAGO. EPIDEMIOLOGIA; ADENOCARCINOMA DE ESOFAGO; CARCINOMA DE CELULAS ESCAMOSAS DO ESOFAGO; ADENOCARCINOMA GASTRICO; NEOPLASIAS GASTRICAS |
| 23194/34351 | US=44 / Gastro Anderson MR, Jankowski J. Factors involved in carcinogenesis and prevention. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 14-20. ISBN 978-1-4051-2783-7. |
| 23195/34351 | US=44 / Gastro Lovell M, Bhan C, Jankowski J, McDonald S. Molecular biology of gastroesophageal cancers: the role of mutational analysis in prognosis. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 21-30. ISBN 978-1-4051-2783-7. CANCER GASTROESOFAGICO; CANCER GASTRICO. BIOLOGIA MOLECULAR; ANALISE MUTACIONAL NO PROGNOSTICO; CANCER ESOFAGICO. BIOLOGIA MOLECULAR; CARCINOMA DE CELULAS ESCAMOSAS ESOFAGICAS; ADENOCARCINOMA ESOFAGICO |